Valuation (33%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 54.24 | 16.53 |
| PEG Ratio (TTM) | 2.09 | 1.69 |
| P/S Ratio (TTM) | 4.02 | 2.62 |
| P/B Ratio (TTM) | 0.95 | 1.93 |
| P/FCF Ratio (TTM) | 18.80 | 11.13 |
| Price to 5YR AVG Earnings Ratio | N/A | 14.11 |
| Price to 5YR AVG FCF Ratio | N/A | 8.09 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.27% | 1,541.34% |
| ROE (TTM) | 2.00% | 8.94% |
| Net Profit Margin (TTM) | 6.82% | 15.71% |
| ROIC 5YR AVG | N/A | 20.59% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -16.13% | N/A | N/A |
| Revenue | 24.16% | N/A | N/A |
| Net Income | -13.08% | N/A | N/A |
| Cash Flow | 29.03% | N/A | N/A |
Health (61%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 17.33 | 3.20 |
| Quick Ratio (TTM) | 34.66 | 4.91 |
| D/E Ratio (TTM) | 0.08 | 1.27 |
| Interest Coverage (TTM) | 0.14 | 0.64 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 0.44 | 0.38 |
| LTL to 5YR AVG FCF | N/A | 6.33 |
| Shares Outstanding Growth 5YR AVG | N/A | 4.87% |